ONCY
Oncolytics Biotech, Inc. Common Shares
Healthcare •
Biotechnology •
stocks •
XNAS
• usd
$0.90
+$0.02
(+2.53%)
Loading...
SMA 20: -
SMA 50: -
SMA 200: -
| General | Valuation | Profitability | Financial Health | Trading | Ownership |
|---|---|---|---|---|---|
| Market Cap | $96.85M | EPS (ttm) | $-0.29 | Current Price | $0.90 |
| Enterprise Value | $84.01M | Forward EPS | $-0.25 | Previous Close | $0.88 |
| P/E Ratio | - | ROA | -111.21% | 52W High | $1.51 |
| Forward P/E | -3.63 | ROE | -769.06% | 52W Low | $0.33 |
| PEG Ratio | - | Gross Margin | - | 50 Day Avg | $1.00 |
| P/S Ratio | - | Operating Margin | - | 200 Day Avg | $0.95 |
| P/B Ratio | 1227.66 | Profit Margin | - | Volume | 7.11M |
| EV/EBITDA | -2.41 | Current Ratio | 1.84 | Avg Volume | 875.42K |
| EV/Sales | - | Quick Ratio | 1.62 | Beta | 0.95 |
| Employees | 28.00 | Debt/Equity | 726.09 | Shares Outstanding | 107.61M |
| Sector | Healthcare | Total Debt | $835.00K | Float Shares | 104.02M |
| Industry | Biotechnology | Total Cash | $12.35M | Short Float | 3.60% |
| Optionable | - | Cash/Share | $0.12 | Short Ratio | 5.64 |
| Dividend Yield | - | Book Value/Share | $0.00 | % Held by Insiders | 2.63% |
| Target Price | $5.55 | Revenue (TTM) | - | % Held by Institutions | 2.42% |